Skip navigation

 Login or Register | Member Centre

Posted AT 2:34 PM EST on 04/04/08

Possible buyer emerges for Draxis

The Canadian Press

TORONTO — Jubilant Organosys Ltd., an India-based integrated pharmaceuticals industry player, is growing in North America by bidding to acquire Canadian drug producer Draxis Health Inc. for $255-million (U.S.). Jubilant is offering $6.00 per share for Toronto-based Draxis in a friendly takeover announced Friday. Draxis, with 500 employees, has its manufacturing operations in Montreal.

The full text of this article has 706 words.

To continue reading this article, you will need to purchase this article.

Already have a member account? Login now

Pay-Per-View Offers To read the complete article, select one of the following options

Purchasing from globeandmail.com is quick and secure.

Single Article: $4.95

4-pack: $17.95

Back to top